• Blog
  • x

    We are working from home under lockdown. Our team is continuously tracking the impact of COVID-19 across different industries and we will incorporate those insights in our reports. For any specific query, mail us at [email protected]

    Pneumonia Vaccines Market | Covid-19 Impact Analysis

    Pneumonia Vaccines Market | Covid-19 Impact Analysis

    Pneumonia Vaccines Market | Covid-19 Impact Analysis
    Report code - SRHL186 Delivery - 2 Weeks
    Pneumonia Vaccines Market Size, Share, Trend, Forecast, & Industry Analysis – 20 See more...
    Purchase Report
    notch

    Pneumonia Vaccines Market Insights

    Pneumonia Vaccines Market is likely to witness an impressive CAGR of 5.0% during the forecast period.  Growing prevalence of chronic diseases such as chronic obstructive pulmonary disease, diabetes mellitus and chronic heart disease, pneumococcal contamination within the population, introduction of novel pneumococcal vaccines, increasing support of government in creating awareness about pneumonia immunization programs are some of the major factors accelerating the growth of the market during the forecast period.

    Pneumonia Vaccines Market – Snapshot

    Growth

    5.0% for the next five years

    Major Product Type

    Pneumonia Conjugate Vaccines

    Region with the highest demand

    Asia-Pacific

    Key Players

    GlaxoSmithKline Plc., LG Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Bioscience, and Walvax Biotechnology Co., Ltd.

     

    Market Share Analysis

    Pneumonia-Vaccines-Market-Dominant-Segments

    Wish to Get a Free Sample? Register Here

    Pneumonia Vaccines Market Share: Product Type

    Based on the product type, the market is segmented as pneumonia conjugate vaccines and pneumonia polysaccharide vaccines.  The pneumonia conjugate vaccine is estimated to be the larger product type in the market owing to its ability to immunize infants and children from the age of 6 weeks to 5 years, providing prevention from invasive disease, pneumonia, and acute otitis media. There has been an increase in the adoption and usage of pneumonia conjugate vaccines amongst the population as many people are vulnerable to pneumonia including children below 5 years and adults above 50 years as well. On the contrary, pneumonia polysaccharide vaccine is estimated to be the faster-growing segment in the market. The growth is attributed to the Pneumovax 23 which has been proven very effective in protecting healthy young adults from invasive pneumonia disease, fueling the product demand during the forecast period.

    Pneumonia Vaccines Market Share: By Region

    In terms of regions, it has been observed that Asia-Pacific is leading the market with India being the major country witnessing significant growth rate, attributed to increasing prevalence of pneumonia and growing mortality associated with the disease which is expected to fuel the product demand during the forecast period. Further, the government getting strong fund from Global Alliance of Vaccines and Immunization for being more accessible to pneumonia vaccines and increasing affordability will accelerate the growth of the regional market over the forecast period. North America and Europe are also expected to offer substantial growth opportunities during the forecast period.

    Pneumonia-Vaccines-Market-By-Region

    Know which region offers best growth opportunities. Register Here

    Some of the key players in the pneumonia vaccines market are-

    • GlaxoSmithKline Plc.
    • LG Chem Ltd.
    • Merck & Co., Inc.
    • Panacea Biotec Limited
    • Pfizer Inc.
    • Pnuvax Incorporated
    • Serum Institute of India Pvt. Ltd.
    • Shenzhen Kangtai Biological Products Co., Ltd.
    • SK Bioscience
    • Walvax Biotechnology Co., Ltd.

     

    Market Scope & Segmentation

    Pneumonia is a disease which causes lung contamination by bacterial or viral infection of the air sacs in one or both of  the lungs, and is commonly found in adults.   

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

    Pneumonia Vaccines Market Research Report - Features

    Market Segmentation

    2

    Regions Covered

    4

    Countries/Sub-Regions Covered

    17

    No. of Figures & Tables

    >150

    Company Profiles

    10

     

    The pneumonia vaccines market is segmented into the following categories. 

    Pneumonia Vaccines Market Size, Share, & Forecast, by Product Type:

    • Pneumonia Conjugate Vaccines (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Pneumonia Saccharide Vaccines (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Pneumonia Vaccines Market Size, Share, & Forecast, by Region:

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Pneumonia-Vaccines-Market-Segmentation

    Want to know the most attractive market segments? Register Here

    Research Methodology

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

     

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

     

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the product types by region type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected]


    Frequently Asked Questions (FAQs)

    What will be the growth of Pneumonia Vaccine Market in the foreseeable future?

    The pneumonia vaccine market is expected to witness an impressive growth of 5.0% CAGR in the foreseeable future.

    Who are the key players in the Pneumonia Vaccine Market?

    GlaxoSmithKline Plc., LG Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Bioscience, and Walvax Biotechnology Co., Ltd are among the key players in the pneumonia vaccine market.

    Which country/region is leading the Pneumonia Vaccine Market?

    Asia-Pacific is leading the pneumonia vaccine market with India being the major country witnessing significant growth rate.

    Which product type is expected to be the larger segment in the Pneumonia Vaccine Market?

    The pneumonia conjugate vaccine is estimated to be the larger product type in the pneumonia vaccine market in the coming years.

    •   
    FREE SAMPLE